Research Tracker›Biomarker Atlas›Marker Pages›Pyruvate dehydrogenase activity

Pyruvate dehydrogenase activity: biomarker evidence

Pyruvate dehydrogenase activity appears in 1 entry of the OSMF biomarker atlas, covering ME/CFS. Across those entries it is reduced in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

ME/CFS

Where Pyruvate dehydrogenase activity is reported

Also listed as: PDH complex

ConditionDirectionCompared againstAssociated symptomsSource
ME/CFS↓ reducedhealthy controlsAerobic metabolism impairmentHolden et al. 2020

Frequently asked questions

In which conditions is Pyruvate dehydrogenase activity altered?

In the OSMF atlas Pyruvate dehydrogenase activity is reported in ME/CFS. It is reduced in 1 across 1 entries.

Is there a standard clinical test for Pyruvate dehydrogenase activity?

The atlas entries for Pyruvate dehydrogenase activity do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Pyruvate dehydrogenase activity result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Pyruvate dehydrogenase activity across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/pyruvate-dehydrogenase-activity.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.